美国制药公司 " Medicure Inc. " ,在8月21日提交 " Q2 2025 " 财务结果。 Medicure Inc., a U.S. pharmaceutical firm, to present Q2 2025 financial results on Aug 21.

以美国为重点的一家制药公司 " Medicure Inc. " 将在8月21日东部时间8时30分的电话会议上介绍其2025年6月30日终了的季度的财务结果。 Medicure Inc., a U.S.-focused pharmaceutical company, will present its financial results for the quarter ending June 30, 2025, during a conference call on August 21 at 8:30 am Eastern Time. 财务细节将在8月20日市场关闭后在他们的网站上公布。 The financial details will be available on their website after the market closes on August 20. AGGTRASTAT和ZYPITAMAG的医药市场,并在全美和波多黎各经营药店。 Medicure markets AGGRASTAT® and ZYPITAMAG® and operates pharmacies across the U.S. and Puerto Rico.